Abstract:Current immunotherapies utilise antibodies to inhibit or aid immunological functions, or as delivery vehicles capable of targeting therapeutic drugs to the immune system. However, the limitations of antibodies compromise the growth of the field of immunotherapy and thus investigations into new avenues should be fast-tracked. One potential avenue is the use of aptamers. Aptamers are single-stranded pieces of DNA that, through the formation of unique 3D-structures specific to the sequence, have the capacity to bind virtually any molecule of interest due to their creation through systematic evolution of ligands by exponential enrichment, or SELEX. They have shown to exhibit great potential for immunotherapies and specifically, mitigate the limitations presented by antibodies. Aptamers can be developed to bind cell surface receptors that play a role in the immunological response. Furthermore, direct conjugation with immunostimulants such as antigenic peptides or adjuvants could elicit direct and tailored responses. A receptor of interest is the class V C-type lectin receptor, Clec9A. Clec9A is found on a small subset of dendritic cells and its restricted nature makes it highly desirable for targeted antigen delivery. In this study, I hypothesised that a novel Hybrid-SELEX approach would generate aptamers with high affinity and specificity to their cognate target. This was tested by utilising the Hybrid-SELEX to develop a DNA aptamer to Clec9A. This was achieved by firstly enriching a random oligonucleotide library to recombinant Clec9A immobilized on magnetic beads and then to its natural state as cell receptors on CD8+ cDCs. A bioinformatics pipeline was applied to NGS data to identify potential aptamers that bind Clec9A which was based on a range of criteria shown to be indicative of target affinity. These included reads per million, cluster number, enrichment, and rank. Candidate aptamers were screened for their affinity to Clec9A using two established characterization techniques, a modified gold nanoparticle assay, and circular dichroism (CD) spectroscopy. CD spectroscopy results found four candidate aptamers that were suggested to exhibit an affinity to Clec9A, however, further experiments will need to be performed to confirm this. Furthermore, this study highlights the necessity for standardized and robust characterization procedures to obtain reproducible, comparable, and reliable results. In summary, A novel hybrid approach of SELEX technology found four potential aptamer candidates that exhibited specific binding interactions towards Clec9a.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule

Engineering Circular Aptamer Assemblies with Tunable Selectivity to Cell Membrane Antigens in Vitro and in Vivo.

De Novo Evolution of an Antibody‐Mimicking Multivalent Aptamer via a DNA Framework

In silico design of novel aptamers utilizing a hybrid method of machine learning and genetic algorithm

Programming DNA Aptamer Arrays of Prescribed Spatial Features with Enhanced Bioavailability and Cell Growth Modulation

Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment

Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

In Silico Discovery of Aptamers with an Enhanced Library Design Strategy.

Rationally Designed Multivalent Aptamers Targeting Cell Surface for Biomedical Applications

Aptamers from Cell-based Selection for Bioanalysis and Bioimaging

Aptamers Generated from Cell-Systematic Evolution of Ligands Through Exponential Enrichment and Their Applications

Assembly of aptamer conjugates as molecular tools in therapeutics

Structural Optimization and Interaction Study of a DNA Aptamer to L1 Cell Adhesion Molecule

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment

The Study of a Hybrid-SELEX Method for the Development and Characterisation of an Aptamer to the Dendritic Cell Surface Receptor: Clec9A

Aptamers As Theranostic Agents: Modifications, Serum Stability and Functionalisation

Recent Developments in Protein and Cell-Targeted Aptamer Selection and Applications.

A high-dimensional microfluidic approach for selection of aptamers with programmable binding affinities

Progress in selection and biomedical applications of aptamers

Identification of DNA Aptamers toward Epithelial Cell Adhesion Molecule via Cell-SELEX